Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Risedronate reduces intracortical porosity in women with osteoporosis.

Risedronate reduces intracortical porosity in women with osteoporosis. J Bone Miner Res. 2010 Jan; 25(1):41-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.